“The Amazing Meeting” (I don’t think it means, what you think it says it means): 2 Intellectually and Ethically Challenged Individuals, Twaddle at TAM 2013

Gentlemen, I start your Insolence 😇
——————————————————————
(1:30) [1]
——————————————————————
The “motto” of “The Amazing (Not so Much) Meeting” is “Fighting Fakers,” which is apropos, since I doubt that “Orac” the “Check my Facts” Hack of Dr. David H. Gorski, grasps the irony, that when I read some of his blog articles, you could easily switch his name with the name of some individual he is flogging, and the proverbial shoe fits, and:
——————————————————————
(1:40)
——————————————————————
“This is a guy who sometimes fools even, you know, physicians”
——————————————————————
(I couldn’t have said it better, myself) 😊
——————————————————————
(2:47)
——————————————————————
He states:

“There is a long segment about “The Skeptics”

(applause) 😝
——————————————————————
(4:25)
——————————————————————
“His lawyer wrote a book”

“About a half of it is about Burzynski [4]
——————————————————————
6:00
——————————————————————
Gorski mentions that Burzynski noticed that there were higher levels of these chemicals in healthy people, than people with cancer
——————————————————————
Whereas, Burzynski is on record as having said [5]:

” . . . healthy people have abundance of these chemicals in blood
Cancer patients have varied to none

I did NOT know before now, that GorskGeek thinks that “none” is a “level” 😶
——————————————————————
He continues:

AS2.1 – which is a chemical called phenylacetic acid, which is a byproduct of metabolism that turns into phenylacetylglutamine by the liver

A10 – soluble is basically the same thing
It breaks down to PAG
——————————————————————
WOW !

I thought it was: AS2 1 😊

They are “basically the same thing” ? 😳

What does Burzynski say ? [6]

Phenylacetylglutaminate (PG) and Phenylacetate (PN) are metabolites of Phenylbutyrate (PB) and are constituents of antineoplaston AS2-1

PG and PN are naturally occurring in human body as result of metabolism of phenylalanine in liver and kidneys

formulation of antineoplaston AS2-1 is 4:1 mixture of synthetic PN and PG

A10 is 4:1 mixture of PG and iso-PG

That does NOT look like “basically the same thing” to me 😛

20131111-160455.jpg
——————————————————————
(6:50)
——————————————————————
Gorski founders on:

“And these are substances which were actually studied in the ’50’s and ’60’s and not found to be particularly, um, promising, but, he didn’t know that then”
——————————————————————
GorskGeek has #FAILED miserably to prove that on his blogs [7] 😄
——————————————————————
(8:00)
——————————————————————
Gorski comments about Burzynski’s “animal testing,” “species specific” claims:

“There are ways of getting around that”
——————————————————————
But Gorski, again, has #FAILED miserably to prove it [8] 😅
——————————————————————
(12:00)
——————————————————————
Gorski makes lame excuses about the NCI phase II clinical trial [9] 😖
——————————————————————
(12:50)
——————————————————————
Gorski claims Burzynski was indicted for insurance fraud in the 1997 case 😱
——————————————————————
GorskGeek, care to try and prove that one also ? [10] 😃
——————————————————————
(14:25)
——————————————————————
Gorski then states that out of 61 trials on clinicaltrials . gov, “most” are “closed or unknown”
——————————————————————
GorskGeek #FAILED again 😁

At the time it was:

1 – Not Yet Recruiting
(OPEN)(Phase 3)
1 – COMPLETED
2 – WITHDRAWN
(Withdrawn due to slow enrollment)
7 – WITHDRAWN
(This study has been withdrawn prior to enrollment)
(9=WITHDRAWN)
10 – Recruiting
(10=OPEN)
40 – Active, not recruiting –
(40=CLOSED)
61 =TOTAL
——————————————————————
(15:20)
——————————————————————
Gorski attempts to go all “legal eagle”:

“Listen to Burzynski’s lawyer!”

“You listen to Burzynski’s lawyer; and, and I swear I don’t understand, like why Burzynski would let him, let his lawyer say stuff this damning in his own book, but he does”

“So, get a load of some of these quotes, referring to one of the clinical trials, he says:”

“It was a joke”

“. . . there could not be any possibility of meaningful data coming out of the so-called clinical trial, it was all an artifice, that, you know, designed so that they could continue giving the treatment

“The FDA wanted all of his patients to be on an IND, so, that’s what we did”
——————————————————————
Gorski, attorney Rick Jaffe is an American, living in America NOT the formerly communist Poland

He can say whatever he wants

GorskGeek is NOT a lawyer 😓

And there’s an excellent reason why

Nor is he schooled in the proper usage of the English language

FACT:

” . . . the so-called clinical trial . . .”

Any human being with a modicum of intelligence about the English language, understands that the term “clinical trial” is singular, i.e. one

Burzynski’s lawyer is obviously referring to the CAN-1 clinical trial mentioned in Burzynski’s 11/25/1997 Securities and Exchange Commission (SEC) filing [11]

One trial that is retrospective is CAN-1 Clinical Trial
——————————————————————
CAN-1 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

PATIENTS WITH REFRACTORY MALIGNANCIES

133 patients
——————————————————————
Clinical trial of patients treated by Dr. Burzynski through 2/23/1996

FDA has indicated it will not accept data generated by this trial since it was not a wholly prospective one
——————————————————————
Gorski continues his trend of #FAILURES when he mentions the additional types of treatments that Burzynski was offering, but he #FAILED to mention [12] 😂
——————————————————————
” … in 1997, his medical practice was expanded to include traditional cancer treatment options such as chemotherapy, gene targeted therapy, immunotherapy and hormonal therapy in response to FDA requirements that cancer patients utilize more traditional cancer treatment options in order to be eligible to participate in the Company’s Antineoplaston clinical trials”
——————————————————————
(18:20)
——————————————————————
Gorski addresses the case of Tori Moreno
——————————————————————
Kim Moreno states:

“We originally were at Miller’s Children at Long Beach Memorial and then went to City of Hope

“We also sent her MRI’s to Dr. Fred Epstein in New York to be looked at”

Gorski suggests that 3 different opinions could have misdiagnosed Tori Moreno

You can read an interview with Tori’s mother [13]
——————————————————————
(19:45)
——————————————————————
Gorski goes on to mention Burzynski patients going to Texas Children’s Hospital with hypernatremia issues
——————————————————————
Gorski, do you mean this ? [14]

The changing pattern of hypernatremia in hospitalized children

Department of Pediatrics, Texas Children’s Hospital, Baylor College of Medicine, Houston, Texas, USA
——————————————————————
(20:00)
——————————————————————
Gorski mangles the case of Hannah Bradley, who had a grade 3 anaplastic astrocytoma brain tumor

GorskGeek makes excuses like “spontaneous remission”, but then provides no citation, reference, or link to a case of such a tumor having spontaneously exhibited remission [15]
——————————————————————
(20:40)
——————————————————————
Gorski states that antineoplastons are chemotherapy
——————————————————————
No, Gorski, antineoplaston are:

“…an unapproved drug, not ordinary “chemotherapy [16] 😣
——————————————————————
(21:53)
——————————————————————
Gorski claims in regard to Burzynski’s personalized gene-targeted therapy:

” . . . gives to the patient without regard for synergistic toxicity

“Boom, there you go”
——————————————————————
Gorski’s #FAIL rate continues, as Burzynski has stated that phase 2 and 3 publications are reviewed as part of this process [17]

Gorski, “BOOM, THERE YOU GO”
——————————————————————
Gorski, you should hire out to the Democratic Party as their mascot, because you must be the biggest pompous ASS I’ve ever seen 😜

Gorski, my advice: don’t quit your day job, HACK 😷
——————————————————————
The #TAM2013 audience then has to suffer through 22:36 of the blatherskite of Robert J. (don’t call me Bobby) “Bob” Blaskiewicz Blatherskitewicz [2]

He blathers about the “dozen,” “17,” “16 dead,” “pancreatic cancer,” “Joseph, who was alive but died well within the life expectancy given his diagnosis,” “Joann, who was alive but died within a year of starting therapy,” “Irene S., who was dead within month,” “Maxine, who was already dead,” the “103 in 2011,” “63 in mid-June,” “17 on original 1999 site,” “about 3 added a year,” the “about 50 stories,” “1/10th of patient names gathered,” “Amelia S. – 7, tumor breaking up,” “Chase,” “Cody – 1994, 20 years ago, 2 visits, 6 weeks treatment breaking up,” “David,” “Janet, 3 – 5 yrs., oncologist, now dead, ovarian cancer,” “Pete took video down,” “8,000 patients,” “probable ischemic necrosis,” “13 yr. old, getting worse getting better, vomited – Marlene, nurse,” “Rory died 2005,” “Supatra, swelling, last wed., brain tumor,” “Side-effect, 2%, sodium load,” “Andrea, U.S. News and World Report, 30% chance recovery, glioblastoma, ANP in luggage, died on plane,” “Cathy wanted to be on ANP, Greg Burzynski, found out only brain tumor,” “Denise D. breast cancer,” and finally:
——————————————————————
(18:45)
——————————————————————
” … and light as many fires under his butt as we can
——————————————————————
Mentions Rick Jaffe’s book Galileo’s Lawyer

IT’S ALL ABOUT THE PATIENTS [4]
——————————————————————
All you need to know about Blaskiewicz is:

“White man speak with forked tongue” [18]
——————————————————————
The 3rd video is a panel discussion, which includes “man-crush” tag-team [3]

Robert Blaskiewicz and David Gorski
——————————————————————
(8:00)
——————————————————————
Bob says:

“Yeah, I’m not that type of doctor
——————————————————————
Bob, the correct answer for you, is:

“I’m NOT a doctor” QUACK
——————————————————————
(13:05)
——————————————————————
Gorski gabs that he’s a:

“Game of Thrones Geek”
——————————————————————
I just knew I was right, GorskGeek [19]
——————————————————————
(14:00)
——————————————————————
The only female panelist mentions “bureaucrats”, “wimps”, and “people without balls”
——————————————————————
2 out of 3 ain’t bad

She describes the Bob and David show to a T
——————————————————————
(15:00)
——————————————————————
The claim is made that a Burzynski physician appeared on the Burzynski Facebook page announcing results
——————————————————————
(16:00)
——————————————————————
Gorski #whines that the Texas Medical Board wasn’t successful in shutting Burzynski down because of “politics”
——————————————————————
LAUGHABLE
——————————————————————
(20:55)
——————————————————————
Gorski gives his usual excuse:

“He’s not an oncologist”
——————————————————————
GorskiGeek, that claim is as dead as apparently, quite a number of your brain cells [15]
——————————————————————
(34:40)
——————————————————————
Audience members are given the opportunity to speak, and this is the garbage served up:
——————————————————————
“Hi, this is Susan

Ah, don’t forget to mention that Wikipedia has been a major battlefield

We’ve had 23,000 views to the clinic’s page this last month, also rebutr . . .”
——————————————————————
“Control the flow of information”
——————————————————————
Gorski pipes up:

“What she said”
——————————————————————
(35:20)
——————————————————————
Blatherskitewicz chimes in:

“When it comes to Wikipedia can I just mention that is, that is, that that is so effective that Wikipedia was singled out in the most recent Burzynski movie
——————————————————————
Gorski chirps:

“Yes”
——————————————————————
Bob yacks:

“as being controlled by evil skeptics
——————————————————————
Gorski ejaculates:

“No, seriously”
——————————————————————
Bob bleats:

“No”

(applause)
——————————————————————
“You have to unleash the evil hoards of skeptics

“Wahahaha” 👿
——————————————————————
Dr. Stanislaw Burzynski on Wikipedia:

“Simply don’t pay attention to it, because it, it’s not true”

“You won’t be able to, do any, clinical research which we do, without convincing evidence, especially when you have the most powerful agency in the government which is against you

“So they would love to find something which is wrong with what we are doing”

“Ah, so the fact that they’ve, um, agreed that what we have has value, and they allow us to do phase 3 clinical trials it means that we are right”

“Because, uh, uh, nobody who didn’t have any, concrete evidence that it works, would be able to go as far”

“So whatever Wikipedia says, well, I don’t care for them

(laughing) [5]
——————————————————————
Enlightening ?

Inspiring ?

Amazing ?

Hypocrites

Apparatchiks [20]
======================================
REFERENCES:
======================================
[1]David Gorski – Why We Fight (Part I): Stanislaw Burzynski Versus Science-Based Medicine – TAM 2013 11/8/2013 (22:44)
——————————————————————

======================================
[2]Robert Blaskiewicz – Why We Fight (Part II): It’s All About The Patients – TAM 2013 11/8/2013 (22:36)
——————————————————————

======================================
[3] – Medical Cranks And Quacks
TAM 2013 JREF
11/8/2013 (42:42)
——————————————————————

======================================
[4]“Galileo’s Lawyer” Richard A. Jaffe, Esq.
——————————————————————
http://www.richardjaffe.com
======================================
[5] – 11/9/2013 – Pete Cohen chats with Dr. Stanislaw Burzynski:
——————————————————————
https://stanislawrajmundburzynski.wordpress.com/2013/11/09/pete-cohen-chats-with-dr-stanislaw-burzynski/
======================================
[6] – 6/2012 – Journal of Cancer Therapy, 2012, 3, 192-200 doi:10.4236/jct.2012.33028 Published Online June 2012, Pg. 192
——————————————————————
http://www.burzynskiclinic.com/images/stories/Publications/9219.pdf
======================================
[7]Burzynski: Oh, RATS!!!:
——————————————————————
https://stanislawrajmundburzynski.wordpress.com/2013/07/26/the-lancet-oncology-peer-review-team-d-12-01519-fail-2/
======================================
[8] – Critiquing: How Stanislaw Burzynski became Burzynski the Brave Maverick Doctor, part 1:
——————————————————————
https://stanislawrajmundburzynski.wordpress.com/2013/07/22/critiquing-how-stanislaw-burzynski-became-burzynski-the-brave-maverick-doctor-part-1/
======================================
[9] – 9/19/2013 – Critiquing: National Cancer Institute (NCI) at the National Institutes of Health (NIH) CancerNet “fact sheet”:
——————————————————————
https://stanislawrajmundburzynski.wordpress.com/2013/09/19/critiquing-national-cancer-institute-nci-at-the-national-institutes-of-health-nih-cancernet/
======================================
[10] – 9/25/2013 – Critiquing: National Council Against Health Fraud, Inc. – NCAHF News: JURY NULLIFICATION THWARTS BURZYNSKI CONVICTION:
——————————————————————
https://stanislawrajmundburzynski.wordpress.com/2013/09/25/critiquing-national-council-against-health-fraud-inc-ncahf-news-jury-nullification-thwarts-burzynski-conviction/
======================================
[11] – 7/9/2013 – Burzynski: The Original 72 Phase II Clinical Trials:
——————————————————————
https://stanislawrajmundburzynski.wordpress.com/2013/07/09/burzynski-the-original-72-phase-ii-clinical-trials/
======================================
[12] – 4/26/2013 – Burzynski: FDA requirements that cancer patients utilize more traditional cancer treatment options in order to be eligible to participate in the Company’s Antineoplaston CLINICAL TRIALS:
——————————————————————
https://stanislawrajmundburzynski.wordpress.com/2013/04/26/burzynski-fda-requirements-that-cancer-patients-utilize-more-traditional-cancer-treatment-options-in-order-to-be-eligible-to-participate-in-the-companys-antineoplaston-clinical-trials/
======================================
[13] – Tori Moreno
——————————————————————
http://www.cancerinform.org/aburzinterview2.html
======================================
[14] – 9/1999 – Pediatrics. 1999 Sep;104(3 Pt 1):435-9
——————————————————————
http://www.ncbi.nlm.nih.gov/m/pubmed/10469766/
======================================
[15] – 11/2/2013 – Critiquing: Dr. Stanislaw Burzynski’s cancer “success” stories:
——————————————————————
https://stanislawrajmundburzynski.wordpress.com/2013/11/02/critiquing-dr-stanislaw-burzynskis-cancer-success-stories/
——————————————————————
10/25/2013 – Hannah Bradley – I Feel Empowered, In Control Of My Body: Four Women On Fighting Cancer With Alternative Therapies http://www.telegraph.co.uk/health/10383724/I-feel-empowered-in-control-of-my-body-four-women-on-fighting-cancer-with-alternative-therapies.html
——————————————————————
https://stanislawrajmundburzynski.wordpress.com/2013/10/25/hannah-bradley-i-feel-empowered-in-control-of-my-body-four-women-on-fighting-cancer-with-alternative-therapies-httpwww-telegraph-co-ukhealth10383724i-feel-empowered-in-control-of-my-body-fo/
======================================
[16] – NOT ORDINARY CHEMOTHERAPY
——————————————————————
https://bulk.resource.org/courts.gov/c/F3/27/27.F3d.153.93-2071.html
======================================
[17] – 9/4/2013 – University of Michigan, where is alum Dr. David H. “Orac” Gorski’s Grapefruits ?:
——————————————————————
https://stanislawrajmundburzynski.wordpress.com/2013/09/04/university-of-michigan-where-is-alum-dr-david-h-orac-gorskis-grapefruits/
======================================
[18] – 10/13/2013 – Why “The Skeptics™” Perfessor Robert J. (don’t call me “Bobby”) “Bob” Blaskiewicz (@rjblaskiewicz) of University of Wisconsin, Eau Claire, “Fame,” is a Coward and a Liar:
——————————————————————
https://stanislawrajmundburzynski.wordpress.com/2013/10/13/why-the-skeptics-perfessor-robert-j-dont-call-me-bobby-bob-blaskiewicz-rjblaskiewicz-of-university-of-wisconsin-eau-claire-fame-is-a-coward-and-a-liar/
======================================
[19] – 10/27/2013 – “The Skeptics™” Burzynski Bias, Censorship, Lies, and Alibi’s: September 28, 2013 “The Skeptics™” Burzynski discussion: By Bob Blaskiewicz – 2:19:51
——————————————————————
https://stanislawrajmundburzynski.wordpress.com/2013/10/27/the-skeptics-lie-lied-lies-liars-lying-burzynski-bias-censorship-lies-and-alibis-september-28-2013-the-skeptics-burzynski-discussion-by-bob-blaskiewic/
======================================
[20] – 11/9/2013 – Wikipedia Articles:
——————————————————————
https://stanislawrajmundburzynski.wordpress.com/2013/09/11/burzynski-timeline/
======================================

Burzynski: The Original 72 Phase II Clinical Trials

11/25/1997 – FORM 10-SB
http://pdf.secdatabase.com/2573/0000950110-97-001598.pdf
� � � � � � � � � � � � � � � � �
1 trial that is retrospective is CAN-1 Clinical Trial
——————————————————————
CAN-1

PATIENTS WITH REFRACTORY MALIGNANCIES
——————————————————————
Clinical trial of patients treated by Dr. Burzynski through 2/23/1996

Analysis has been made of patients with PRIMARY MALIGNANT BRAIN TUMORS (PMBT) in CAN-1 trial:

40 evaluable patients

17 experienced more than 50% reduction in size of tumors, of whom 7 had complete disappearance of tumor

FDA has indicated it will not accept data generated by this trial since it was not a wholly prospective one
=======================================
As of 10/1997, only 2 clinical trials have reached a Milestone
� � � � � � � � � � � � � � � � �
“Clinical Trial BT-11”
——————————————————————
BT-11

PATIENTS WITH BRAIN STEM GLIOMA
——————————————————————
Another trial of Clinical Trial BT-11 involves patients with brain stem glioma

5/1996 trial approved by FDA

After accrual of 12 patients:

1 complete response
3 partial response
� � � � � � � � � � � � � � � � �
“Clinical Trial BT-18”
——————————————————————
BT-18

ADULT PATIENTS WITH MIXED GLIOMA
——————————————————————
Clinical Trial BT-18

intravenous administration of Antineoplastons A10 and AS2-1 in

treatment of “mixed glioma”, a type of PRIMARY MALIGNANT BRAIN TUMORS (PMBT)
——————————————————————
3/1996 was approved by FDA

Results evaluated after 9 patients accrued:

2 complete responses
2 partial responses
� � � � � � � � � � � � � � � � �
ACTIVE PHASE II CLINICAL TRIALS
=======================================
Title of Protocol

Subject of Protocol and Date

Number of Persons Enrolled

Number of Patients who may Participate in the Study
=======================================
AD-2 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

PATIENTS WITH CARCINOMA OF THE ADRENAL GLAND

2
40
——————————————————————
BL-2 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

PATIENTS WITH CARCINOMA OF THE BLADDER

3
40
——————————————————————
BR-10 PROTOCOL FOR RANDOMIZED CONTROLLED TRIAL COMPARING METHOTREXATE TREATMENT ALONE TO THE COMBINATION OF METHOTREXATE AND ANTINEOPLASTON A10

7
40
——————————————————————
BR-12 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

PATIENTS WITH CARCINOMA OF THE BREAST

17
40
——————————————————————
BR-14 PHASE II STUDY OF ANTINEOPLASTON A10 AND AS2-1 CAPSULES IN

PATIENTS WITH ADVANCED BREAST CANCER

6
40
——————————————————————
BR-6 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 INFUSIONS IN

CHILDREN WITH HIGH GRADE GLIOMA

9
40
——————————————————————
BT-7 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

PATIENTS WITH GLIOBLASTOMA MULTIFORME

34
40
——————————————————————
BT-8 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

PATIENTS WITH ANAPLASTIC ASTROCYTOMA

9
40
——————————————————————
BT-9 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

PATIENTS WITH BRAIN TUMORS

11
40
——————————————————————
BT-10 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

CHILDREN WITH BRAIN TUMORS

5
40
——————————————————————
BT-11 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

PATIENTS WITH BRAIN STEM GLIOMA

15
40
——————————————————————
BT-12 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

CHILDREN WITH PRIMITIVE NEUROECTODERMAL TUMORS; (PNET)

5
40
——————————————————————
BT-13 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

CHILDREN WITH LOW GRADE ASTROCYTOMA

7
40
——————————————————————
BT-14 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

CHILDREN WITH RHABDOID TUMOR OF THE CENTRAL NERVOUS SYSTEM

3
40
——————————————————————
BT-15 PHASE II STUDY OF ANTINEOPLASTON A10 AND AS2-1 IN

ADULT PATIENTS WITH ANAPLASTIC ASTROCYTOMA

17
40
——————————————————————
Pg. 7
=======================================
BT-16 PHASE II STUDY OF ANTINEOPLASTON A10 AND AS2-1 IN

ADULT PATIENTS WITH LOW GRADE ASTROCYTOMA

5
40
——————————————————————
BT-17 PHASE II STUDY OF ANTINEOPLASTON A10 AND AS2-1 IN

ADULT PATIENTS WITH OLIGODENDROGLIOMA

5
40
——————————————————————
BT-18 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

ADULT PATIENTS WITH MIXED GLIOMA

12
40
——————————————————————
BT-19 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

PATIENTS WITH NEUROFIBROMA AND SCHWANNOMA

0
40
——————————————————————
BT-20 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

ADULT PATIENTS WITH GLIOBLASTOMA MULTIFORME

35
40
——————————————————————
BT-21 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

ADULT PATIENTS WITH PRIMARY MALIGNANT BRAIN TUMORS

19
40
——————————————————————
BT-22 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

CHILDREN WITH PRIMARY MALIGNANT BRAIN TUMORS

4
40
——————————————————————
BT-23 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 INFUSIONS IN

CHILDREN WITH VISUAL PATHWAY GLIOMA

2
40
——————————————————————
BT-24 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 INFUSIONS IN

PATIENTS WITH EPENDYMOMA

7
40
——————————————————————
BT-25 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 INFUSIONS IN

PATIENTS WITH CRANIOPHARYNGIOMA

0
40
——————————————————————
BT-26 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 INFUSIONS IN

PATIENTS WITH CHOROID PLEXUS NEOPLASM

1
40
——————————————————————
BT-27 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 INFUSIONS IN

PATIENTS WITH GERM CELL TUMOR OF THE BRAIN

0
40
——————————————————————
BT-28 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 INFUSIONS IN

PATIENTS WITH MENINGIOMA

2
40
——————————————————————
CAN-1 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

PATIENTS WITH REFRACTORY MALIGNANCIES

133
133
——————————————————————
CO-2 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

PATIENTS WITH ADENOCARCINOMA OF THE COLON

12
40
——————————————————————
CO-3 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 CAPSULES IN

PATIENTS WITH ADENOCARCINOMA OF THE COLON

4
40
——————————————————————
ES-2 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

PATIENTS WITH ADENOCARCINOMA OF THE ESOPHAGUS

4
40
——————————————————————
HB-2 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

CHILDREN WITH HEPATOBLASTOMA

0
40
——————————————————————
Pg. 8
=======================================
HE-2 PHASE II STUDY OF ANTINEOPLASTONS A10 IN

PATIENTS WITH PRIMARY LIVER CANCER

1
40
——————————————————————
HN-2 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

PATIENTS WITH CARCINOMA OF THE HEAD AND NECK

6
40
——————————————————————
LA-3 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

PATIENTS WITH ADENOCARCINOMA OF THE LUNG

13
40
—————————————————————–
LA-4 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

PATIENTS WITH LARGE CELL, UNDIFFERENTIATED CARCINOMA OF THE LUNG

4
40
——————————————————————
LA-5 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

PATIENTS WITH BRONCHIAL ALVEOLAR CARCINOMA OF THE LUNG

1
40
—————————————————————–
LA-6 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

PATIENTS WITH SQUAMOUS CELL CARCINOMA OF THE LUNG

5
40
——————————————————————
LA-7 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

PATIENTS WITH SMALL CELL CARCINOMA OF THE LUNG

2
40
——————————————————————
LA-10 PHASE II STUDY OF ANTINEOPLASTON A10 AND AS2-1 CAPSULES IN

PATIENTS WITH NON SMALL CELL LUNG CANCER

9
40
——————————————————————
LY-3 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

PATIENTS WITH NON-HODGKIN’S LYMPHOMA

2
40
——————————————————————
LY-6 PHASE II STUDY OF ANTINEOPLASTON A10 AND AS2-1 IN

PATIENTS WITH NON-HODGKIN’S LYMPHOMA, LOW GRADE

18
40
——————————————————————
LY-7 PHASE II STUDY OF ANTINEOPLASTON A10 AND AS2-1 IN

PATIENTS WITH NON-HODGKIN’S LYMPHOMA, INTERMEDIATE GRADE

10
40
——————————————————————
LY-8 PHASE II STUDY OF ANTINEOPLASTON A10 AND AS2-1 IN

PATIENTS WITH NON-HODGKIN’S LYMPHOMA, HIGH GRADE

1
40
——————————————————————
LY-9 PHASE II STUDY OF ANTINEOPLASTON A10 AND AS2-1 IN

PATIENTS WITH MANTLE ZONE LYMPHOMA

4
40
——————————————————————
LY-10 PHASE II STUDY OF ANTINEOPLASTON A10 AND AS2-1 WITH

CHRONIC MYELOGENOUS LEUKEMIA

0
40
——————————————————————
LY-11 PHASE II STUDY OF ANTINEOPLASTON A10 AND AS2-1 IN

PATIENTS WITH MYCOSIS FUNGOIDES – SEZARY SYNDROME

0
40
——————————————————————
LY-12 PHASE II STUDY OF ANTINEOPLASTON A10 AND AS2-1 IN

PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

0
40
——————————————————————
LY-13 PHASE II STUDY OF ANTINEOPLASTON A10 AND AS2-1 IN

PATIENTS WITH PRIMARY LYMPHOMA OF THE GASTROINTESTINAL TRACT

0
40
——————————————————————
LY-14 PHASE II STUDY OF ANTINEOPLASTON A10 AND AS2-1 INFUSIONS IN

PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

2
40
——————————————————————
Pg. 9
=======================================
MA-2 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

PATIENTS WITH MESOTHELIOMA

4
40
——————————————————————
ME-2 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

PATIENTS WITH MALIGNANT MELANOMA

8
40
——————————————————————
MF-2 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

PATIENTS WITH MALIGNANT FIBROUS HISTIOCYTOMA

0
40
——————————————————————
MM-2 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

PATIENTS WITH MULTIPLE MYELOMA

5
40
——————————————————————
MW-2 PHASE II STUDY OF ANTINEOPLASTON A10 AND AS2-1 IN

PATIENTS WITH MACROGLOBULINEMIA OF WALDESTROM

0
40
——————————————————————
NB-2 PHASE II STUDY OF ANTINEOPLASTON A10 AND AS2-1 IN

PATIENTS WITH NEUROBLASTOMA

1
40
——————————————————————
NE-2 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

PATIENTS WITH NEUROENDOCRINE TUMORS

3
40
——————————————————————
OV-2 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

PATIENTS WITH CARCINOMA OF THE OVARY

5
40
——————————————————————
PA-2 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

PATIENTS WITH CARCINOMA OF THE PANCREAS

11
40
——————————————————————
PN-2 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

PATIENTS WITH PRIMITIVE NEUROECTODERMAL TUMOR OUTSIDE THE CENTRAL NERVOUS SYSTEM

1
40
——————————————————————
PR-4 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

PATIENTS WITH ADENOCARCINOMA OF THE PROSTATE

11
40
——————————————————————
PR-5 PHASE II STUDY OF

ADENOCARCINOMA OF THE PROSTATE

WITH ANTINEOPLASTON A10 AND AS2-1 CAPSULES

16
40
——————————————————————
PR-6 PHASE II STUDY OF ANTINEOPLASTON A10 AND AS2-1 CAPSULES IN COMBINATION WITH TOTAL ANDROGEN BLOCKADE IN

PATIENTS WITH ADENOCARCINOMA OF THE PROSTATE

0
40
——————————————————————
PR-8 PHASE II STUDY OF ANTINEOPLASTON A10 AND AS2-1 IN

PATIENTS WITH ADENOCARCINOMA OF THE PROSTATE

0
40
——————————————————————
RN-2 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

PATIENTS WITH CARCINOMA OF THE KIDNEY

9
40
——————————————————————
SA-2 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

PATIENTS WITH SOFT TISSUE SARCOMA

8
40
——————————————————————
SI-2 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

PATIENTS WITH CARCINOMA OF THE SMALL INTESTINE

1
40
——————————————————————
ST-2 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

PATIENTS WITH ADENOCARCINOMA OF THE STOMACH

6
40
——————————————————————
UC-2 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

PATIENTS WITH CARCINOMA OF THE UTERINE CERVIX AND/OR VULVA

8
40
——————————————————————
10
=======================================
UP-2 PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN

PATIENTS WITH CARCINOMA OF AN UNKNOWN PRIMARY

6
40
——————————————————————
WT-2 PHASE II STUDY OF ANTINEOPLASTON A10 AND AS2-1 IN

PATIENTS WITH WILMS’ TUMOR

2
40
——————————————————————